Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID-Reference-Cited by-同舟云学术

Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID

Published:2020-08-19 Issue:11 Volume:115 Page:1812-1820
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Chapuis-Biron Constance,Kirchgesner Julien,Pariente Benjamin,Bouhnik Yoram,Amiot Aurélien,Viennot Stéphanie,Serrero Mélanie,Fumery Mathurin,Allez Matthieu,Siproudhis Laurent,Buisson Anthony,Pineton de Chambrun Guillaume,Abitbol Vered,Nancey Stéphane,Caillo Ludovic,Plastaras Laurianne,Savoye Guillaume,Chanteloup Elise,Simon Marion,Dib Nina,Rajca Sylvie,Amil Morgane,Parmentier Anne-Laure,Peyrin-Biroulet Laurent,Vuitton Lucine,

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference30 articles.

1. AGA technical review on perianal Crohn's disease;Sandborn;Gastroenterology,2003

2. A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease;Gecse;Gut,2014

3. 3rd European Evidence-Based Consensus on the Diagnosis and Management of Crohn's disease 2016: Part 1: Diagnosis and medical management;Gomollón;J Crohns Colitis,2017

4. Predictors of Crohn's disease;Beaugerie;Gastroenterology,2006

5. Development of an index to define overall disease severity in IBD;Siegel;Gut,2018

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08

2. Allogenic Stem Cells in Anal Fistulas of Crohn’s Disease: From Promising Premises to Real Life Experience;Inflammatory Bowel Diseases;2024-06-11

3. Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU;Digestive and Liver Disease;2024-06

4. Ustekinumab or Vedolizumab after Failure of Anti-TNF Agents in Crohn’s Disease: A Review of Comparative Effectiveness Studies;Journal of Clinical Medicine;2024-04-10

5. Safety and Effectiveness of Ustekinumab for Crohn’s Disease With Perianal Manifestations: Ad hoc Analysis Data From 1-Year Post-Marketing Surveillance Study in Japan;Crohn's & Colitis 360;2024-04-01